1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready • 3 patents granted in the last 365 days
Form Bio Inc. is currently managing 1 pending office action. This prosecution activity is overseen by 1 distinct examiner, FUELLING, MICHAEL, within 1 distinct art unit. FUELLING, MICHAEL serves as the busiest examiner for the company, holding 1 busiest examiner pending action.
The concentration of the docket under 1 distinct examiner suggests a streamlined review process for the company. Because the matter is situated in 1 distinct art unit, the administrative footprint is narrow. The 1 pending office action represents the entirety of the company's active patent prosecution at the present time.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 only | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| FUELLING, MICHAEL | 1 | 44.1% | +31.1% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18150404 | SYSTEMS AND METHODS FOR MODIFYING NUCLEIC ACID SEQUENCES TO ENHANCE COMPOUND PRODUCTION | FUELLING, MICHAEL | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18150404 | SYSTEMS AND METHODS FOR MODIFYING NUCLEIC ACID SEQUENCES TO ENHANCE COMPOUND PRODUCTION | FUELLING, MICHAEL | — |
| Art Unit | Apps |
|---|---|
| 3992 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18150404 | SYSTEMS AND METHODS FOR MODIFYING NUCLEIC ACID SEQUENCES TO ENHANCE COMPOUND PRODUCTION | FUELLING, MICHAEL | 3992 | §101 | Final Rejection | — | Pending | Jan 05, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialForm Bio Inc. has 1 pending office actions as of October 2026, spread across 1 art units and 1 examiners.
Michael Fuelling has the most, with 1 of Form Bio Inc.'s pending office actions.
